April 10, 2025 14:15 ET | Source: Transgene S.A. Transgene S.A.
Document d'Enregistrement Universel 2024
Pièces jointes
Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
Document d'Enregistrement Universel 2025 Pièces jointes TRANSGENE_DEU_2025_FR 969500PDJW8N0FSGGK69-2025-12-31-1-fr ...
